Lack of long-term changes in circadian, locomotor, and cognitive functions in acute and chronic MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) mouse models of Parkinson's disease.
about
Executive function deficits and glutamatergic protein alterations in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.Circadian system - A novel diagnostic and therapeutic target in Parkinson's disease?Alteration of daily and circadian rhythms following dopamine depletion in MPTP treated non-human primates.Changes in Motor Activity and the Sleep–Waking Cycle in an MPTP Model of Parkinson’s Disease in Mice
P2860
Lack of long-term changes in circadian, locomotor, and cognitive functions in acute and chronic MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) mouse models of Parkinson's disease.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Lack of long-term changes in c ...... models of Parkinson's disease.
@en
Lack of long-term changes in c ...... models of Parkinson's disease.
@nl
type
label
Lack of long-term changes in c ...... models of Parkinson's disease.
@en
Lack of long-term changes in c ...... models of Parkinson's disease.
@nl
prefLabel
Lack of long-term changes in c ...... models of Parkinson's disease.
@en
Lack of long-term changes in c ...... models of Parkinson's disease.
@nl
P2093
P2860
P1476
Lack of long-term changes in c ...... models of Parkinson's disease.
@en
P2093
Howard M Cooper
Karim Fifel
Ouria Dkhissi-Benyahya
P2860
P304
P356
10.3109/07420528.2012.762011
P407
P577
2013-06-12T00:00:00Z